Statistical power considerations in genotype-based recall randomized controlled trials

Naeimeh Atabaki-Pasdar1, Mattias Ohlsson2, Dmitry Shungin1

  • 1Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmö, SE-205 02, Sweden.

Scientific Reports
|November 26, 2016
PubMed

Insights

Genotype-based recall (GBR) trials offer greater statistical power for detecting gene-treatment interactions compared to conventional randomized controlled trials (RCTs). This study highlights GBR

Area of Science:

  • Pharmacogenomics
  • Clinical Trial Design
  • Biostatistics

Background:

  • Randomized controlled trials (RCTs) frequently lack the statistical power to validate gene-treatment interactions.
  • The Diabetes Prevention Program (DPP) provides valuable data for examining trial power.
  • Gene-treatment interactions are crucial for personalized medicine and drug efficacy.

Purpose of the Study:

  • To compare the statistical power of genotype-based recall (GBR) and conventional randomized controlled trials (RCTs) for validating gene-treatment interactions.
  • To assess the impact of different sampling frames and outcome measurement errors on trial power.
  • To evaluate the strengths and weaknesses of GBR designs in gene-treatment interaction studies.

Main Methods:

  • Utilized published data from the Diabetes Prevention Program (DPP).
  • Calculated sample size and statistical power for gene-metformin interactions using specific genetic variants (rs8065082 SLC47A1).
  • Simulated power for interactions involving genetic risk scores (GRS), metformin, and intensive lifestyle intervention (ILI) under various scenarios, including GBR and conventional sampling.

Main Results:

  • Genotype-based recall (GBR) trials demonstrated substantially higher statistical power than conventional RCTs of equivalent size for detecting gene-drug and gene-lifestyle interactions.
  • The study quantified power for both time-to-event (type 2 diabetes incidence) and continuous (small LDL particle change) outcomes.
  • GBR designs showed significant advantages across most simulated scenarios.

Conclusions:

  • Genotype-based recall (GBR) designs offer a more powerful approach for validating gene-treatment interactions compared to traditional RCTs.
  • GBR trials are a valuable tool for personalized medicine research, but their specific strengths and limitations require careful consideration.
  • The findings underscore the potential of GBR for enhancing the efficiency of genetic research in clinical trials.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
518
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.2K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
359
Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.2K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
348
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
11.0K